Share
Journal Information
Most often read
4142
ABO discrepancy resolution in two patients with acute myeloid leukemia presenting the transient weak expression of A antigenMarcos Paulo Miola, Tharsis Cardoso de Oliveira, Andrea Aparecida Garcia Guimarães, Octávio Ricci-Junior, Luiz Carlos de Mattos
Hematol Transfus Cell Ther. 2024;46:85-8
4142
Full text access
2499
Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-upKaira Mara Cordeiro de Albuquerque, Caroline Brandão Joventino, Lia Correia Moreira, Hermano Alexandre Lima Rocha, Lívia Andrade Gurgel, Deivide de Sousa Oliveira, Carlos Ewerton Maia Rodrigues
Hematol Transfus Cell Ther. 2024;46:8-13
2499
Full text access
2409
Role of therapeutic plasma exchange as a desensitization therapy in human leukocyte antigen incompatible renal transplant patients: A single-center experienceMohit Chowdhry, Ayushi Yadav, Vandana Sharma, Soma Agrawal
Hematol Transfus Cell Ther. 2024;46:42-8
2409
Full text access
2010
Production of dendritic cell vaccines using different methods with equivalent results: Implications for emerging centersAdriana da Silva Santos Duarte, Audrey Basso Zangirolami, Irene Santos, Fernanda Soares Niemann, Helen Naemi Honma, Emerson Clayton Amaro, Maurício Wesley Perroud, Fernando Vieira Pericole, ... Sara Teresinha Olalla Saad
Hematol Transfus Cell Ther. 2024;46:30-5
2010
Full text access
1597
Diffuse large B-cell non-Hodgkin's lymphoma associated with still's disease and macrophage activation syndrome: Rare report in the literatureFernanda Marcante Carlotto, Nathalia Beck Corrêa, Daiane Weber, Cristiane Zanotelli
Hematol Transfus Cell Ther. 2024;46:80-4
1597
Full text access
1540
Haploidentical hematopoietic stem cell transplantation and complex congenital heart disease: a treatment challenge case reportDiego Medina-Valencia, Ana María Aristizabal, Estefania Beltran, Alexis A. Franco, Walter Mosquera
Hematol Transfus Cell Ther. 2024;46:89-92
1540
Full text access
1526
All-trans retinoic acid-induced myositis in a 36-year-old patient with acute promyelocytic leukaemia: Case report and literature reviewMarcelo Junqueira Atanazio, Guilherme Henrique Hencklain Fonseca
Hematol Transfus Cell Ther. 2024;46:72-6
1526
Full text access
1498
Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statementMargareth Castro Ozelo, Sandra Vallin Antunes, Paula Ribeiro Villaca, Luciana Correa Oliveira, Ieda Solange Pinto, Claúdia Santos Lorenzato, Alessandra Nunes Loureiro Prezotti, Renato Mantelli Picoli
Hematol Transfus Cell Ther. 2024;46:36-41
1498
Full text access
1260
Venous thromboembolism in COVID-19 and inherited thrombophiliaEster Martins Camillozzi Medina, Daniel Dias Ribeiro, Maria Sueli Silva Namen-Lopes, Suely Meireles Rezende
Hematol Transfus Cell Ther. 2024;46:93-5
1260
Full text access
1232
Hemograms and serial hemogram-derived ratios in survivors and non-survivors of COVID-19 in Campinas, BrazilAdekunle Emmanuel Alagbe, Gisele Audrei Pedroso, Beatriz Benedetti de Oliveira, Edivilson da Costa, Gisélia Aparecida Freire Maia, Bruna Facanali Piellusch, Susan Elisabeth Domingues Costa Jorge, Fernando Ferreira Costa, ... Magnun Nueldo Nunes Santos
Hematol Transfus Cell Ther. 2024;46:14-21
1232
Full text access
1216
Successful lung transplant in a patient with a combined thrombophiliaVíctor Manuel Mora Cuesta, Sandra Tello Mena, David Iturbe Fernández
Hematol Transfus Cell Ther. 2024;46:77-9
1216
Full text access
1179
Serial values of hematologic variables and deep venous thrombosis: Red cell distribution width is associated with deep venous thrombosisGovind R. Patel, Manoranjan Mahapatra, Sadhna Aggarwal, Renu Saxena
Hematol Transfus Cell Ther. 2024;46:22-9
1179
Full text access
1155
Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR systemAbbas Hajifathali, Maryam Vahdat Lasemi, Maryam Mehravar, Mohammad Reza Moshari, Afshin Mohammad Alizadeh, Elham Roshandel
Hematol Transfus Cell Ther. 2024;46:58-66
1155
Full text access
1127
The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional studyEsma Eryilmaz-Eren, Zeynep Ture, Ayşin Kilinç-Toker, Serdal Korkmaz, İlhami Çelik
Hematol Transfus Cell Ther. 2024;46:3-7
1127
Full text access
1077
Small bowel intussusception from an underlying MALT Lymphoma: A double rarity case reportMariana Dias Coelho, Cristiana Sequeira, Ricardo Freire, Ana Paula Oliveira
Hematol Transfus Cell Ther. 2024;46:96-8
1077
Full text access
748
What are the hurdles in the pathway of COVID-19 convalescent plasma collection in low-income nations?Sahjid Mukhida, Johnson Subhash, Chanda Vyawahare, Nikunja Kumar Das
Hematol Transfus Cell Ther. 2024;46:99-100
748
Full text access
713
Bone marrow histoplasmosis-the hidden culprit in an immunodeficiency settingSubhajit Hajra, Ratna Mondal, Monika Maharjan, Nishi Jha, Bhartendu, Prabhat Rijal, Ravi Kant, Arvind Kumar Gupta
Hematol Transfus Cell Ther. 2024;46:106-7
713
Full text access
708
Immunothrombosis and its underlying biological mechanismsArthur Cunha De Nardi, Andréa Coy-Canguçu, Atena Saito, Maria Fernanda Florio, Giovanna Marti, Giovanna R. Degasperi, Fernanda A. Orsi
Hematol Transfus Cell Ther. 2024;46:49-57
708
Full text access
636
Hemophagocytosis in acute myeloid leukemiaClaudia Morales-Olvera, Fernando Pérez-Jacobo
Hematol Transfus Cell Ther. 2024;46:108-9
636
Full text access
573
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemiaJean Carlos Lipreri da Silva, Juan Luiz Coelho-Silva, Hugo Passos Vicari, Keli Lima, Eduardo Magalhães Rego, Fabiola Traina, João Agostinho Machado-Neto
Hematol Transfus Cell Ther. 2024;46:101-5
573
Full text access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.